ReCerf®’s BIOLOX®delta ceramic-on-ceramic hip resurfacing shows strong 5-year results for women
An international team of ADEPT® resurfacing experts led by Dr. Paul Beaulé (Ontario, Canada) analyzed the performance of MatOrtho Ltd’s ReCerf® hip resurfacing – the BIOLOX®delta ceramic system, which recently received a CE marking – on both female and male patients and in small-size components.
Key Takeaways
98% overall implant survival was reported among 604 patients (336 men, 268 women) aged 20-80 at five years’ post-op, with a mean follow-up of 4.04 years.
128 hips reached the five-year follow-up, and 10 revisions occurred. Of these, 1 was related to the implant, with a unique and documented case of detachment of the bonding.
The 5-year survival rates were as follows:
- Women: 98.5%
- Men: 97.6%
- Femoral head sizes <50 mm: 98.5%
- Femoral head sizes ≥50 mm: 97.5%
No significant difference in revision risk was reported based on patient sex (female HR 0.79, p=0.780) or femoral head size (HR 1.01, p=0.890).
Significant improvements were observed in both Oxford Hip Score (OHS) and UCLA Activity Scale scores for all patients post-CoCHR.
Beaulé et al. posit the ReCerf® system as a potential bone-preserving option for a broader range of patients, including women and those requiring smaller femoral head sizes – which addresses a major limitation of metal resurfacing. While long-term follow-up will add vital context and support, these early results suggest that BIOLOX®delta ceramic technology is already shaping the next generation of hip replacement.
Join us at the International Society for Technology in Arthroplasty (ISTA)in Rome September 17-20 for a deep dive into all things on ceramic resurfacing, from lectures to cadaver lab, lunch symposium or hands on with our partner MatOrtho Ltd.
Please check for regulatory approval in your country.
References:
Koh CK, Walter WL, Yates P, et al. Influence of head size and sex on the five-year survival of ceramic-on-ceramic hip resurfacing: an international multicentre study. Bone Joint J. 2025;107-B(7):691-697. doi:10.1302/0301-620X.107B7.BJJ-2024-1594.R1.
This post was created with the support of AI.